Objectives: The aims of this non-randomized qualitative study were to compare the quality of life (QOL) of breast cancer survivors who received hormone replacement therapy (HRT) and those who didnot, and to describe the impact of breast cancer on their social, physical, psychological and spiritual domains. A QOL self-evaluation questionnaire was used to determine the most important concerns andchanges described by women that affected, or were likely to affect, their QOL as a result of breast cancer.Methods: In total, 220 patients who had finished treatment for breast cancer werecontacted; 190 agreed to participate, of whom 123 (64.8%) completed and returned their questionnaires, which comprised demographic data, Quality of Life Breast Cancer Version Questionnaire and Quality ofLife Self Evaluation Questionnaire. The results for women taking HRT were compared with results for those who were not.Results: There were no significant differences in time between surgeryfor breast cancer and the survey, age at last birthday, number of pregnancies and live births, employment, breast cancer surgery and adjuvant therapy between HRT and non-HRT groups. No differences werefound in the social, physical, psychological and spiritual domains between the two groups; however, significant differences were found between survival time and quality of life in some domains. During thestudy, none of the 123 women developed a recurrence of their breast cancer.Conclusion: There were no significant differences in any demographic variables between the users of HRT and thenon-users. The same level of QOL was observed between HRT and non-HRT groups in the four domains of well-being. The majority of women with breast cancer recovered to a near normal level of QOL after a 4-yearadjustment period, and lead fulfilling lives. This adjustment period cannot be quantified, as individual factors such as emotional, social and financial concerns will differ for each individual.